Today starts classes in San Jacinto College's new center. Photo via sanjac.edu

San Jacinto College is gearing up to open the Center for Petrochemical, Energy, and Technology at its main campus in Pasadena — a $60 million project designed to bolster the Houston area's petrochemical workforce.

On August 21, the community college hosted media tours of the Center for Petrochemical, Energy, and Technology (CPET). The center will welcome more than 2,800 students August 26 and host a grand opening September 18. The college broke ground on the 151,000-square-foot center in September 2017.

At CPET, future and current petrochemical workers will learn about process operations, troubleshooting, nondestructive testing, instrumentation, and myriad other aspects of the industry. In all, CPET will offer 75 courses. The center's highlights include an 8,000-square-foot glycol distillation unit, 35 labs, and 19 classrooms. San Jacinto College bills the center as the largest petrochemical training site in the Gulf Coast region.

"Four years ago, a team came together from San Jacinto College and the East Harris County Manufacturers Association to put together a long-term plan for workforce development," says Jim Griffin, associate vice chancellor at San Jacinto College and senior vice president of petrochemical, energy, and technology. "The Center for Petrochemical, Energy, and Technology was part of that plan and is now a reality."

Griffin says the curriculum, classrooms, and labs were "designed and influenced" by the petrochemical industry.

Among CPET's more than 20 partners are:

  • Emerson, which donated more than $1.3 million worth of services and equipment.
  • INEOS Olefins & Polymers USA, which contributed $250,000 in cash.
  • Dow Chemical, which donated $250,000 in cash.

All three of those employers — and many others in the region — depend on schools like San Jacinto College to contribute to the pool of highly trained workers in the petrochemical sector.

"We expect to see a higher-than-normal level of retirements over the next five plus years; rebuilding our workforce is critical at this time," Jeff Garry, Dow Chemical's operations director in the Houston area, said when his company's CPET donation was announced. "The need to train and adequately staff our assets will continue to be a pressing concern. As the labor market becomes more competitive for talent, we understand the importance to attract and retain highly skilled and educated workers."

With four campuses in Harris County, San Jacinto College promotes itself as a training hub for the country's largest petrochemical manufacturing complex, featuring 130 plants and employing about 100,000 people. CPET will serve as the centerpiece of that hub. Overall, the community college says it "plays a vital role in helping the region maintain its status as the 'Energy Capital of the World.'"

PetrochemWorks.com — a petrochemical career initiative whose backers include JPMorgan Chase & Co., the Council for Adult and Experiential Learning, and the East Harris County Manufacturing Association — says the local petrochemical industry will need 19,000 more skilled workers annually over the next three to five years.

"Chronic shortages of skilled labor are increasing costs and schedules and resulting in declining productivity, lower quality, more accidents, and missed objectives," according to Petrochemical Update, a news website.

Although robots are on the rise in many industries, Mark Mills, a senior fellow at the Manhattan Institute who's an energy and technology expert, believes that as petrochemical companies increasingly turn to automation, productivity will go up, ultimately creating more jobs — not fewer.

"In large part," Mills writes, "it's desperation, not an infatuation with tech or cost savings, that drives employers to deploy technologies that amplify the capabilities of the employees they have and can find. It is a common misconception to think that automation is always cheaper than using labor."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston edtech company closes oversubscribed $3M seed round

fresh funding

Houston-based edtech company TrueLeap Inc. closed an oversubscribed seed round last month.

The $3.3 million round was led by Joe Swinbank Family Limited Partnership, a venture capital firm based in Houston. Gamper Ventures, another Houston firm, also participated with additional strategic partners.

TrueLeap reports that the funding will support the large-scale rollout of its "edge AI, integrated learning systems and last-mile broadband across underserved communities."

“The last mile is where most digital transformation efforts break down,” Sandip Bordoloi, CEO and president of TrueLeap, said in a news release. “TrueLeap was built to operate where bandwidth is limited, power is unreliable, and institutions need real systems—not pilots. This round allows us to scale infrastructure that actually works on the ground.”

True Leap works to address the digital divide in education through its AI-powered education, workforce systems and digital services that are designed for underserved and low-connectivity communities.

The company has created infrastructure in Africa, India and rural America. Just this week, it announced an agreement with the City of Kinshasa in the Democratic Republic of Congo to deploy a digital twin platform for its public education system that will allow provincial leaders to manage enrollment, staffing, infrastructure and performance with live data.

“What sets TrueLeap apart is their infrastructure mindset,” Joe Swinbank, General Partner at Joe Swinbank Family Limited Partnership, added in the news release. “They are building the physical and digital rails that allow entire ecosystems to function. The convergence of edge compute, connectivity, and services makes this a compelling global infrastructure opportunity.”

TrueLeap was founded by Bordoloi and Sunny Zhang and developed out of Born Global Ventures, a Houston venture studio focused on advancing immigrant-founded technology. It closed an oversubscribed pre-seed in 2024.

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.